López-Cano, CarolinaCiudin, AndreeaSánchez, EnricTinahones, Francisco JBarbé, FerranDalmases, MireiaGarcía-Ramírez, MartaSoto, AlfonsoGaeta, Anna MichelaPellitero, SilviaMartí, RaquelHernández, CristinaSimó, RafaelLecube, Albert2023-05-032023-05-032022http://hdl.handle.net/10668/20499To evaluate the effect of liraglutide, a glucagon-like peptide 1 receptor agonist, on pulmonary function and serum levels of surfactant protein D (SP-D) in type 2 diabetes. A double-blind, randomized, crossover, placebo-controlled clinical trial comprising 76 patients with a baseline forced expiratory volume in 1 senAgedBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 2Double-Blind MethodFemaleGlycemic ControlHumansLiraglutideLungMaleMiddle AgedPulmonary Surfactant-Associated Protein DSpainVital Capacityresearch article34737187open access10.2337/db21-06881939-327Xhttps://diabetesjournals.org/diabetes/article-pdf/71/2/315/640899/db210688.pdf